Switch theme
Sign up to access all valuation multiples
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
2017
72K+
LTM Revenue $27.5B
LTM EBITDA $5.6B
$59.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Siemens Healthineers has a last 12-month revenue (LTM) of $27.5B and a last 12-month EBITDA of $5.6B.
In the most recent fiscal year, Siemens Healthineers achieved revenue of $26.4B and an EBITDA of $5.0B.
Siemens Healthineers expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Siemens Healthineers valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $27.5B | XXX | $26.4B | XXX | XXX | XXX |
| Gross Profit | $10.8B | XXX | $10.0B | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $5.6B | XXX | $5.0B | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $4.3B | XXX | $3.3B | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $2.7B | XXX | $2.3B | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Siemens Healthineers's stock price is EUR 47 (or $55).
Siemens Healthineers has current market cap of EUR 52.6B (or $62.0B), and EV of EUR 50.6B (or $59.6B).
See Siemens Healthineers trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $59.6B | $62.0B | XXX | XXX | XXX | XXX | $2.76 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Siemens Healthineers has market cap of $62.0B and EV of $59.6B.
Siemens Healthineers's trades at 2.2x EV/Revenue multiple, and 11.6x EV/EBITDA.
Equity research analysts estimate Siemens Healthineers's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Siemens Healthineers has a P/E ratio of 22.7x.
See valuation multiples for Siemens Healthineers and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $62.0B | XXX | $62.0B | XXX | XXX | XXX |
| EV (current) | $59.6B | XXX | $59.6B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | 11.6x | XXX | XXX | XXX |
| EV/EBIT | 13.9x | XXX | 16.6x | XXX | XXX | XXX |
| EV/Gross Profit | 5.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 22.7x | XXX | 25.5x | XXX | XXX | XXX |
| EV/FCF | 19.6x | XXX | 22.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSiemens Healthineers's last 12 month revenue growth is 6%
Siemens Healthineers's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Siemens Healthineers's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Siemens Healthineers's rule of X is 34% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Siemens Healthineers and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 34% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Siemens Healthineers acquired XXX companies to date.
Last acquisition by Siemens Healthineers was XXXXXXXX, XXXXX XXXXX XXXXXX . Siemens Healthineers acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Siemens Healthineers founded? | Siemens Healthineers was founded in 2017. |
| Where is Siemens Healthineers headquartered? | Siemens Healthineers is headquartered in Germany. |
| How many employees does Siemens Healthineers have? | As of today, Siemens Healthineers has 72K+ employees. |
| Is Siemens Healthineers publicy listed? | Yes, Siemens Healthineers is a public company listed on ETR. |
| What is the stock symbol of Siemens Healthineers? | Siemens Healthineers trades under SHL ticker. |
| When did Siemens Healthineers go public? | Siemens Healthineers went public in 2018. |
| Who are competitors of Siemens Healthineers? | Similar companies to Siemens Healthineers include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Siemens Healthineers? | Siemens Healthineers's current market cap is $62.0B |
| What is the current revenue of Siemens Healthineers? | Siemens Healthineers's last 12 months revenue is $27.5B. |
| What is the current revenue growth of Siemens Healthineers? | Siemens Healthineers revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Siemens Healthineers? | Current revenue multiple of Siemens Healthineers is 2.2x. |
| Is Siemens Healthineers profitable? | Yes, Siemens Healthineers is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Siemens Healthineers? | Siemens Healthineers's last 12 months EBITDA is $5.6B. |
| What is Siemens Healthineers's EBITDA margin? | Siemens Healthineers's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Siemens Healthineers? | Current EBITDA multiple of Siemens Healthineers is 10.7x. |
| What is the current FCF of Siemens Healthineers? | Siemens Healthineers's last 12 months FCF is $3.0B. |
| What is Siemens Healthineers's FCF margin? | Siemens Healthineers's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Siemens Healthineers? | Current FCF multiple of Siemens Healthineers is 19.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
